Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal. Specific details of the lawsuit are not yet available ...

Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae. The $7.22-per-share deal for 89.8% of Sage is a 30 ...

Sage 50 Accounting is desktop accounting software designed for small and medium businesses. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

The Ariel Helwani ShowEverything boxing & MMA from the world and mind of Ariel Helwani. The Kevin O'Connor ShowKevin O'Connor talks ball with the best names from around the world of basketball ...